2015
DOI: 10.1002/wnan.1341
|View full text |Cite
|
Sign up to set email alerts
|

Biomedical applications of gold nanomaterials: opportunities and challenges

Abstract: In the past few years, there has been an unprecedented development of gold nanomaterials (AuNMs) for potential clinical applications. Owing to their advantageous physical, chemical, and biological properties, AuNMs have attracted great attention in the nanomedicine arena for applications in biological sensing, biomedical imaging, drug delivery, and photothermal therapy. Their tunable size, shape, and surface characteristics coupled with excellent biocompatibility render them ideal candidates for translation fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
50
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(50 citation statements)
references
References 140 publications
0
50
0
Order By: Relevance
“…[1][2][3] Silver nanoparticles (AgNPs) have been extensively used in antimicrobial applications, specifically, as antibacterial agents. 4,5 The traditional synthesis of AuNPs involves the use of chemical reducing agents to convert metal salts to metallic nanoparticles via a reduction reaction.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] Silver nanoparticles (AgNPs) have been extensively used in antimicrobial applications, specifically, as antibacterial agents. 4,5 The traditional synthesis of AuNPs involves the use of chemical reducing agents to convert metal salts to metallic nanoparticles via a reduction reaction.…”
Section: Introductionmentioning
confidence: 99%
“…22 Several toxicological reports show that many AuNPs have cytotoxicity in vitro and in vivo. [44][45][46] Furthermore, some AuNPs and silver nanoparticles are able to induce HO-1 expression by causing cytotoxicity and oxidative stress. 19,20,47 However, the AuNPs in this study caused Nrf2 activation and HO-1 expression in a short incubation.…”
mentioning
confidence: 99%
“…13 Generally, however, the use of NPs can be severely limited by various factors, such as their aggregation and precipitation, short half-life in the bloodstream caused by opsonization by plasma proteins, non-specific targeting, and the possible risk of cell and tissue damage. 4 Devising proper surface modification is indeed essential for eliminating or at least minimizing these negative factors and making the NPs more biocompatible and stable in biological environments. Many NPs are small enough to pass through biological barriers and are considered to be very promising materials for biomedical applications.…”
Section: Introductionmentioning
confidence: 99%